You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CSTL Sale Disclosure
Juvenal Tobin W · SEC Form 4 · Filed Aug 4, 2026
Sale
Calculated transaction value
$235.03K
Juvenal Tobin W Chief Commercial Officer
CSTL
Castle Biosciences
CSTL
Transaction date
Jul 31, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 4 days later
CSTL daily price context
Close on/before transaction
$28
Jul 31, 2026
First close after public filing
$30.4
Aug 5, 2026
30-day return after filing
+7.4%
Through Sep 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,149 shares @ $28.84
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-052648
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$556.17K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Castle Biosciences Inc CSTL | Sale | Aug 3, 2026 | $48.87K |
| Castle Biosciences Inc CSTL Current | Sale | Jul 31, 2026 | $235.03K |
| Castle Biosciences Inc CSTL | Sale | Jul 31, 2026 | $215.04K |
| Castle Biosciences Inc CSTL | Sale | Jul 31, 2026 | $57.23K |